Carter Validus Mission Critical REIT II, Inc. – Trademark Portfolio

Entity Type: 03

Carter Validus Mission Critical REIT II, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 5 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include SILA REALTY TRUST. The owner is based in Tampa, FL.

4890 W. Kennedy Boulevard, Suite 650

Tampa, FL 33609

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Carter Validus Mission Critical REIT II, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (5 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Carter Validus Mission Critical REIT II, Inc. have?

Carter Validus Mission Critical REIT II, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.

What trademark classes does Carter Validus Mission Critical REIT II, Inc. file in?

Carter Validus Mission Critical REIT II, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Carter Validus Mission Critical REIT II, Inc.'s most well-known trademarks?

Carter Validus Mission Critical REIT II, Inc.'s registered trademark portfolio includes well-known marks such as SILA REALTY TRUST. These are among 2 currently registered trademarks in the portfolio.

What is Carter Validus Mission Critical REIT II, Inc.'s trademark registration success rate?

Carter Validus Mission Critical REIT II, Inc. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.